Physician

Robert Delaune, M.D.

According to 2025 Medicare claims, Robert Delaune, M.D. (NPI: 1497723514) practices medical oncology in the Minneapolis-St. Paul-Bloomington, MN-WI market, with the plurality of this provider's patient population coming from Ramsey, MN. This provider's primary affiliated billing organization is MINNESOTA ONCOLOGY HEMATOLOGY, PA (NPI: 1528035995; TIN: 411793418) and primary practice location at 55109-1127. Delaune is affiliated with the Collaborative ACO 30, LLC (ACO ID: A5483), participating under the MSSP model.

Delaune's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 633 traditional Medicare patients, billed 236,711 HCPCS/CPT codes, and received $4,018,759 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 2,196 prescription claims across 337 beneficiaries totaling $8,146,608 in drug costs, led by Revlimid (Lenalidomide). 2023 DME data shows 164 claims. Open Payments data shows 1 records totaling $187. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a lower plateau to a higher plateau, from $1,434,514 to $4,018,759. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $2,054,279 to $8,146,608. In contrast, DME billing represents a smaller volume and moved from a lower plateau to a higher plateau, from $2,036 to $5,761.